Sino-US Pficker Pharmaceuticals Announces R&D Breakthrough
This article was originally published in PharmAsia News
Executive Summary
Sino-US Pficker Pharmaceuticals recently announced that its R&D team, the pioneer of oxidative stress window phase theory, has applied the intervention theory in its industrial process. Company officials said the oxidative stress window phase theory has been verified to make disease prevention and treatment safer and more intuitive. As a technology-driven pharmaceutical corporation, Sino-US Pficker owns the worldwide intellectual property of three new drugs' developing techniques. Its "rinse-free" hand detergent, which can kill virus and bacteria quickly and effectively, is in the final stages of approval and will be launched soon. (Click here for more - Chinese Language)